Germany's Stada drives OTC internationalisation

Germany's Stada drives OTC internationalisation

15 February 2018 - Deborah Wilkes


Read all about the latest developments at Stada Arzneimittel in this NEWS EXTRA publication from OTCToolbox.

Stada has new private-equity owners and has just recruited a new permanent chief executive officer from Novartis' Sandoz division. Peter Goldschmidt will be the German generics and OTC company's fifth chief executive officer in around two years.

Meanwhile, Stada's Branded Products business is pushing ahead with the internationalisation of key OTC brands including the Hedrin head-lice treatments, the Fultium vitamin D supplement, and the Ladival range of sunscreen products.

Download the publication today to find out more about Stada's:

  • Strategy of internationalising OTC brands
  • Approach to acquisitions
  • Recent acquisitions
  • Ups and downs in Russia
  • New permanent chief executive officer
  • Recent financial performance

The News Extra is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence. It is available free to people with an Annual Subscription to the OTCToolbox website.

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to News Extras

Share this page: